BIM
KYTH

BlackRock Investment Management’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

BlackRock Investment Management’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-86,326
Closed -$6.47M – 4235
2015
Q3 		$6.47M Sell
86,326
-845
-1% -$63.1K 0.01% 1195
2015
Q2 		$6.57M Buy
87,171
+29,654
+52% +$1.59M 0.01% 1285
2015
Q1 		$2.88M Buy
57,517
+7,392
+15% +$310K ﹤0.01% 1777
2014
Q4 		$1.74M Sell
50,125
-484
-1% -$16.9K ﹤0.01% 2135
2014
Q3 		$1.66M Buy
50,609
+434
+0.9% +$15.3K ﹤0.01% 2138
2014
Q2 		$1.93M Buy
50,175
+17,455
+53% +$609K ﹤0.01% 2098
2014
Q1 		$1.3M Buy
32,720
+250
+0.8% +$11.2K ﹤0.01% 2328
2013
Q4 		$1.21M Buy
32,470
+3,716
+13% +$154K ﹤0.01% 2362
2013
Q3 		$1.31M Buy
28,754
+2,182
+8% +$65.3K ﹤0.01% 2252
2013
Q2 		$719K Buy
+26,572
New +$608K ﹤0.01% 2604

BlackRock Investment Management's KYTH Position: Q4 2015 in Review

BlackRock Investment Management sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 86,326 shares — an estimated $6.47M sold.

BlackRock Investment Management first reported a position in KYTH in Q2 2013 and held it in 10 quarters. The position peaked at $6.57M in Q2 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • BlackRock Investment Management reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • BlackRock Investment Management sold 86,326 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $6.47M.
  • BlackRock Investment Management first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 10 quarters.
  • BlackRock Investment Management's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $6.57M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on BlackRock Investment Management's 13F filing for Q4 2015, filed 11 Feb 2016.